At the time of diagnosis

Staff (percent)

Median age, year

70 (56 - 79)

median PSA, ng/ml

25.1 (4.9 - 3609)

Metastatic disease, n (%)

3 (37.5)

Local treatment of the primary disease, n (%)

6 (75)

Androgenic castration, n (%)

8 (100)

At the time of oligoprogression

Median age, year

73 (60 - 81)

median PSA, ng/ml

3.11 (2.5 - 43.8)

Diagnostic imaging, n (%)

PET-CT (PSMA/Choline)

8 (100)

Conventional imaging

1 (12.5)

Number of progressive lesions, n (%)

1

7 (87.5)

2

1 (12.5)

Types of progressive lesions, n (%)

Bone

8 (87.5)

Local relapse

1 (12.5)

Treatment, n (%)

Radiotherapy

8 (100)

Radiotherapy technique

Stereotaxis

7 (77.77)

3D

2 (22.23)

Fractionation, n lesion

10 Gy × 3 fractions

4 Gy × 5 fractions

12 Gy × 3 fractions

23 Gy × 2 fractions

6 (1)

1 (1)

1 (1)

1(1)